U.S. President Donald Trump is preparing to announce a new agreement with a major pharmaceutical company, reportedly Pfizer, to lower drug prices for Medicaid recipients.
Breakdown
- President Trump is set to announce a pharmaceutical pricing agreement. 6s
- The deal reportedly involves Pfizer selling medications at lower prices through Medicaid. 52s
- The agreement may include a three-year tariff reprieve for US-made products. 37s
- A new initiative, 'Trump Rx,' could allow direct cash purchases of certain drugs from a government website. 1m 48s
- It is unclear if other pharmaceutical companies will participate or how the plan will affect those with insurance. 2m 1s